Pharma Blogs This Week: Hot & Heavy Congressional Committee Hearings, DTC Study Shows No Effect on Pricing, and Another Pharma CFO Bites the Dust
NEWTOWN, Pa., June 8, 2007 – Pharmaceutical bloggers were busy this week discussing the congressional hearings on Avandia, the departure of AstraZeneca CFO Jon Symonds, Michael Moore’s appearance on Oprah, the Villanova University study claiming that DTC has no effect on drug pricing, and Dr. Peter Rost’s profile in this month’s Fortune magazine. Christiane Truelove, editor of Med Ad News and R&D Directions, summarizes the thoughts of popular industry bloggers on these topics.
Mark Senak of Eye on FDA predicts of the congressional hearings on Avandia, “… there is going to be a legislative effort to beef up FDA oversight of post-marketing commitments and maybe direct-to-consumer advertising (DTC) as well.”
Jon Symonds is the fifth CFO to leave a major pharmaceutical company so far this year. Ed Silverman at Pharmalot speculates that Symonds, who is leaving AstraZeneca to become a managing director at Goldman Sachs, may be looking for revenge, asking “…might Symonds view his former employer as a likely target for a merger or buyout?”
John Mack at the Pharma Marketing Blog managed to be invited to an advance screening of Michael Moore’s upcoming film SiCKO. His revelation: SiCKO does not savage the pharmaceutical industry as has been feared by pharma executives. Instead, the film’s wrath is directed toward for-profit health insurance companies.
Read more about these and other topics covered this week by subscribing to the PharmaBlogs: Week in Review eNewsletter. Visit www.pharmalive.com/enewsletters.
About PharmaBlogs: Week in Review
Designed as a time-effective approach to keeping current on the
industry’s blog discussions, PharmaBlogs: Week in Review is
the first online newsletter focused on recapping pharmaceutical
blogs. The e-newsletter is published by industry information
provider Engel Publishing Partners and sent to your e-mail inbox
each Friday.
About Engel Publishing Partners
For 25 years, Engel Publishing Partners has been the source that
pharmaceutical executives turn to for the information they need to
create competitive business strategies. Engel Publishing Partners
carries a full product line, offering industry-leading publications
Med Ad News and R&D Directions, informative newsletters, and
data-rich interactive products. Through these channels, Engel
Publishing Partners disseminates original and un-biased content
that provides insight into industry trends and events, as well as
extensive analysis of companies, products, and pipelines.
###
Pharma Industry News Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
